Tyra Biosciences, Inc. TYRA Return on assets
Return on assets at other companies
Other financials
Where this comes from
Calculated from Tyra Biosciences, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s return on assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s return on assets?
- Tyra Biosciences, Inc. (TYRA) reported return on assets of -34.7% in Q1 2026.
- How has Tyra Biosciences, Inc.'s return on assets changed year-over-year?
- Tyra Biosciences, Inc.'s return on assets decreased by 34.6% year-over-year, from -25.8% to -34.7%.
- What is the long-term trend for Tyra Biosciences, Inc.'s return on assets?
- Over 4 years (2021 to 2025), Tyra Biosciences, Inc.'s return on assets has grown at a 22.9% compound annual growth rate (CAGR), from -16.3% to -37.1%.
- What does return on assets mean?
- Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.